Imaging the Noradrenergic System in Parkinson's Disease: A [11C] Yohimbine PET and Neuromelanin MRI Sstudy

被引：0
|
作者：
Laurencin, C.
Lancelot, S.
Huddlestone, M.
Brosse, S.
Merida, I.
Costes, N.
Redoute, J.
Thobois, S.
Boulinguez, P.
Ballanger, B.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1578
引用
收藏
页码：S694 / S695
页数：2
相关论文
共 50 条
  • [1] Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study
    Laurencin, Chloe
    Lancelot, Sophie
    Brosse, Sarah
    Merida, Ines
    Redoute, Jerome
    Greusard, Elise
    Lamberet, Ludovic
    Liotier, Veronique
    Le Bars, Didier
    Costes, Nicolas
    Thobois, Stephane
    Boulinguez, Philippe
    Ballanger, Benedicte
    BRAIN, 2024, 147 (04) : 1377 - 1388
  • [2] Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study
    Sommerauer, Michael
    Fedorova, Tatyana D.
    Hansen, Allan K.
    Knudsen, Karoline
    Otto, Marit
    Jeppesen, Jesper
    Frederiksen, Yoon
    Blicher, Jakob U.
    Geday, Jacob
    Nahimi, Adjmal
    Damholdt, Malene F.
    Brooks, David J.
    Borghammer, Per
    BRAIN, 2018, 141 : 496 - 504
  • [3] Imaging Parkinson's disease pathology: A comparison between neuromelanin-sensitive MRI, susceptibility weighted imaging and [11C]PE2I DAT PET
    Chandra, A.
    Pagano, G.
    Yousaf, T.
    Wilson, H.
    Politis, M.
    MOVEMENT DISORDERS, 2019, 34 : S133 - S133
  • [4] Functional imaging of tremor in Parkinson's disease with [11C]-WAY 100635 PET
    Doder, M
    Rabiner, EI
    Turjanski, N
    Lees, AJ
    Brooks, DJ
    NEUROLOGY, 2001, 56 (08) : A271 - A272
  • [5] [11C]PHNO and [11C]racloride PET imaging of dopamine receptors in drug-naive Parkinson's disease
    Boileau, Isabelle
    Guttman, Mark
    Houle, Sylvain
    Rusjan, Pablo
    Wilson, Alan A.
    Kapur, Shitij
    Kish, Stephen J.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 228S - 228S
  • [6] Noradrenergic mechanisms in Parkinson's disease, studied with [18F]FDOPA and [11C]MeNER PET
    Kinnerup, M.
    Sommerauer, M.
    Ostergaard, K.
    Borghammer, P.
    Gjedde, A.
    Nahimi, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 47 - 48
  • [7] [11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia
    Jokinen, Pekka
    Scheinin, Noora
    Aalto, Sargo
    Nagren, Kjell
    Savisto, Nina
    Parkkola, Riitta
    Rokka, Johanna
    Haaparanta, Merja
    Roytta, Matias
    Rinne, Juha O.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (10) : 666 - 670
  • [8] Parkinson's disease, impulse control disorder and the D3 dopamine receptor system: Preliminary PET imaging studies with [11C](+)PHNO comparison with [11C]racloride
    Boileau, Isabelle
    Guttman, Mark
    Adams, John R.
    Houle, Sylvain
    Tong, Junchao
    Rusjan, Pablo
    Wilson, Alan
    Kapur, Shitij
    Kish, Stephen J.
    NEUROIMAGE, 2010, 52 : S84 - S84
  • [9] [11C]-PIB imaging in patients with Parkinson's disease:: Preliminary results
    Johansson, A.
    Savitcheva, I.
    Forsberg, A.
    Engler, H.
    Langstrom, B.
    Nordberg, A.
    Askmark, H.
    PARKINSONISM & RELATED DISORDERS, 2008, 14 (04) : 345 - 347
  • [10] Imaging nigrostriatal circuitry with 11C-PE2I PET and neuromelanin-sensitive MR in Parkinson's disease
    Bastida, A. Martin
    Lao-Kaim, N.
    Roussakis, A. -A.
    Politis, M.
    Li, W.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Paul, G.
    Widner, H.
    Foltynie, T.
    Barker, R.
    Piccini, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 920 - 920
12345